Search results (31)
« Back to NewsStrong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
COVID-19 research MRC HIU MRC WIMM
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
COVID-19 patients continue to experience symptoms six months after infection
21 October 2021
Study investigating the long-term impact of moderate to severe COVID-19 finds that a large proportion of COVID-19 patients previously admitted to hospital continue to experience intrusive symptoms six months following infection.
COVID-19 recovery project nominated for HSJ award
15 September 2021
Awards COVID-19 research CVM OCMR
Updated: the project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine was 'highly commended' at the Health Service Journal Awards 2021.
DNA breakthrough could help identify why some people are more affected by Covid-19
10 June 2021
COVID-19 research MRC MHU MRC WIMM
Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.
Role-playing computer game helps players understand how vaccines work on a global scale
8 October 2020
COVID-19 research IMD MRC HIU MRC WIMM
A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.
Persistent immune memory of COVID-19 found in recovered patient T cells
4 September 2020
COVID-19 research IMD MRC HIU MRC WIMM
New Nature Immunology paper finds strong T cell responses in recovered COVID-19 patients